REF: DJFI/DJ70519A THIS DEED is made on June 16, 1997 BETWEEN: -------- 1. THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD whose administrative offices are at Wellington Square, Oxford OX1 2JD, England ("the University"); 2. THE...Leukosite Inc • July 11th, 1997 • Pharmaceutical preparations
LEUKOSITE, INC.Stock Purchase Agreement • November 10th, 1998 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
EXHIBIT 99.2 AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • October 21st, 1999 • Leukosite Inc • Pharmaceutical preparations • Delaware
WHEREAS, the Corporation and the Series G Investors are parties to a Securities Purchase Agreement, dated the date hereof (as amended and in effect from time to time, the "Series G Securities Purchase Agreement"), pursuant to which the Corporation has...Stockholders' Agreement • June 27th, 1997 • Leukosite Inc • Delaware
1 CONFIDENTIAL TREATMENT EXHIBIT 10.3 LICENSE AGREEMENT Effective as of January 2, 1995 ("Effective Date"), THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California...License Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • California
SERVICE AGREEMENTService Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations
LEUKOSITE, INC.Stock Purchase Agreement • August 2nd, 1999 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
LEUKOSITE, INC.Registration Rights Agreement • August 2nd, 1999 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
MORRELL, PEEL & GAMLEN -Solicitors- 1 St Giles Oxford OX1 3JR 2 THIS AGREEMENT dated 6 October 1994 ("the Effective Date") is made between:Leukosite Inc • August 13th, 1997 • Pharmaceutical preparations
R&D AGREEMENT" shall mean the Research, Development and Marketing Agreement between the Corporation and the Investor, 3 - 2 -Preferred Stock Purchase Agreement • June 27th, 1997 • Leukosite Inc • Massachusetts
LEUKON, INC. CONSULTING AGREEMENTConsulting Agreement • June 27th, 1997 • Leukosite Inc • Massachusetts
LICENSE AGREEMENT This Agreement is effective May 2, 1997 ("the Effective Date") by and between LeukoSite, Inc. ("LKS"). a Delaware corporation having an address at 215 First Street, Cambridge, MA 02142, and L & I Partners, L.P., a Delaware Limited...License Agreement • June 27th, 1997 • Leukosite Inc
AGREEMENT OF LIMITED PARTNERSHIP OF L & I PARTNERS, L.P.Leukosite Inc • August 13th, 1997 • Pharmaceutical preparations • Delaware
EXHIBIT 10.17(b) LICENSE AGREEMENT This Agreement is effective May 2, 1997 ("the Effective Date") by and between LeukoSite, Inc. ("LKS"). a Delaware corporation having an address at 215 First Street, Cambridge, MA 02142, and L & I Partners, L.P., a...Confidential Treatment • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations
LEUKON, INC. CONSULTING AGREEMENTConsulting Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
Exhibit 10.1 LEUKOSITE, INC. REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of July 20, 1999 by and among (i) LeukoSite, Inc., a Delaware corporation (the "Company"), (ii) Perseus Capital LLC., a...Registration Rights Agreement • August 17th, 1999 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
C) OA's combinatorial chemistry techniques are still experimental, therefore preparation of the library compounds identified in Appendix B may require a substantial amount to research and development work on the part of OA. Accordingly, OA cannot...Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations
1 Exhibit 10.20(a) THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF...Warrant Agreement • July 11th, 1997 • Leukosite Inc • Pharmaceutical preparations • Delaware
Exhibit 10.4 ESCROW AGREEMENT This Escrow Agreement, dated as of February 11, 1999 (this "Agreement"), is by and among LeukoSite, Inc., a Delaware corporation ("LeukoSite"), Richard Sherman and Joel Liffmann in their capacity as Stockholders'...Escrow Agreement • August 2nd, 1999 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
EXHIBIT 10.1 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION This Agreement and Plan of Merger and Reorganization dated as of January 4, 1999 (this "Agreement"), is by and among LeukoSite, Inc., a Delaware corporation ("LeukoSite"), LeukoSite Merger...Agreement and Plan of Merger and Reorganization • December 3rd, 1999 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
2 3 (a) REMAIN A WARNER PRODUCT. If LeukoSite does not elect to convert such Warner Product to a Warner-LeukoSite Product, LeukoSite and Warner will estimate in good faith the designated share of Development Costs that LeukoSite would have paid under...Leukosite Inc • November 14th, 1997 • Pharmaceutical preparations • Massachusetts
1 EXHIBIT 10.20(b) THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF...Warrant Agreement • July 11th, 1997 • Leukosite Inc • Pharmaceutical preparations • Delaware
a) General Terms. Subject to the terms and conditions of this Security Agreement, Lender hereby agrees to make one or more senior secured loans (each, a "Loan" and collectively, the "Loans") to 2 -2- Borrower, subject to the following conditions: (i)...Loan and Security Agreement • June 27th, 1997 • Leukosite Inc • California
RESEARCH AGREEMENTResearch Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • England
1 EXHIBIT 10.9 CONFIDENTIAL TREATMENT RESEARCH COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • June 27th, 1997 • Leukosite Inc • New York
1 CONFIDENTIAL TREATMENT EXHIBIT 10.8(a) LICENCE AGREEMENT (DOCUMENT IDENTIFICATION CODE: LEUKOSITE/IC/NHLI/0012/LICENCE) THIS AGREEMENT (hereinafter called the "LICENCE AGREEMENT") is made effective the Thirty First day of January, 1996 (hereinafter...Licence Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations
LEUKOSITE, INC. REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of December 18, 1997 by and between LEUKOSITE, INC., a Delaware corporation (the "Company"), and GENENTECH, INC., a Delaware corporation...Registration Rights Agreement • January 26th, 1998 • Leukosite Inc • Pharmaceutical preparations • Delaware
1 CONFIDENTIAL TREATMENT EXHIBIT 10.5 LICENSE AGREEMENT This Agreement is effective March 15, 1995 ("EFFECTIVE DATE") by and between Lynxvale Ltd., having an address at the Old Schools, Cambridge CB2, ITS, England ("LYNXVALE"). and LeukoSite, Inc., a...License Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • England
WITNESSETHDistribution and Development Agreement • September 3rd, 1999 • Leukosite Inc • Pharmaceutical preparations • Delaware
Lessee may sublease the Equipment upon the reasonable consent of the Lessor and the Secured Party. Such consent to sublease will be granted if: (i) Lessee meets the relocation requirements set out above, (ii) the sublease is expressly subject and...Master Lease Agreement • June 27th, 1997 • Leukosite Inc • Illinois
1 Exhibit 10.15 CONFIDENTIAL TREATMENT RESEARCH COLLABORATION AND LICENSE AGREEMENT This Agreement is effective _________________________ , 1997 ("the EFFECTIVE DATE") by and between Kyowa Hakko Kogyo Co. Ltd. (hereinafter referred to as "KHK"), a...Confidential Treatment • June 27th, 1997 • Leukosite Inc • Massachusetts
WITNESSETH:Research and Development Agreement • March 31st, 1999 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
1 CONFIDENTIAL TREATMENT EXHIBIT 10.9 RESEARCH COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • New York
Subject to LESSOR's reserved rights specified above, there shall be appurtenant to the Leased Premises the right to park two (2) passenger motor vehicles per 1,000 feet of occupied square feet in the open, uncovered, parking areas as shown on Exhibit...Leukosite Inc • June 27th, 1997 • Massachusetts
The terms used in this Agreement have the following meaning: 2 -2-Research Collaboration and License Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
